PPA
COGT icon

Parametric Portfolio Associates’s Cogent Biosciences COGT Stock Holding History

Parametric Portfolio Associates’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$211K Buy
+28,131
New +$196K ﹤0.01% 3421
2019
Q2 		– Sell
-3,457
Closed -$61K – 3960
2019
Q1 		$61K Buy
+3,457
New +$59.1K ﹤0.01% 3867

Other funds holding COGT

EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $22.2B AUM 58.34% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return

Parametric Portfolio Associates's COGT Position: Q1 2022 in Review

Parametric Portfolio Associates opened a new position in Cogent Biosciences (COGT) in Q1 2022: 28,131 shares worth $211K. The stake represents ﹤0.01% of the portfolio and ranks #3421 among its holdings. This is a return to the name: Parametric Portfolio Associates previously reported a position in COGT as recently as Q1 2019.

Parametric Portfolio Associates first reported a position in COGT in Q1 2019 and has held it in 2 quarters since. 87 funds tracked by Wall St. Rank hold COGT as of Q1 2022.

  • Parametric Portfolio Associates held 28,131 shares of Cogent Biosciences worth $211K as of Q1 2022.
  • Cogent Biosciences was a new Parametric Portfolio Associates position in Q1 2022.
  • Cogent Biosciences made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #3421 holding.
  • Parametric Portfolio Associates first reported a position in Cogent Biosciences in Q1 2019 and has held it in 2 quarters since.
  • 87 funds tracked by Wall St. Rank held Cogent Biosciences as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.